Green Thumb Industries Inc. ("Green Thumb") (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of RISE Dispensaries opened applications for the third round of its Good Green Grant Program.
"The Good Green Grant Program was born out of the desire to reinvest cannabis funds back into the community and create opportunities for nonprofit organizations who are doing the groundwork to create real and sustained progress against the War on Drugs," said Green Thumb Founder and Chief Executive Officer Ben Kovler. "Through this program, we are supporting nonprofits to help create opportunity and change in impacted communities."
First launched in the fall of 2021, Good Green offers affordable mixed bud flower products. Sales from Good Green products fund grants awarded to nonprofit organizations that give back to communities of color disproportionately affected by the War on Drugs. Since the brand's launch, Good Green has awarded more than $500,000 in grant money to eight organizations who encompass the brand's three core pillars: education, employment and expungement. Good Green is on track to give more than $1 million by the end of year.
Good Green is committed to bringing responsible consumers and change-making organizations together to create real, lasting change. The brand's current product offerings, including indica, sativa and hybrid mixed bud flower products, are available in Illinois, Maryland, Massachusetts, New Jersey, Pennsylvania and Virginia.
The Good Green Grant Program's third round of applications are now open to local 501(c)3 organizations through 11:59 p.m. EST on August 19. For more information on Good Green's nonprofit application process, winners and product, please visit www.good.green .
About Green Thumb Industries: Green Thumb Industries Inc. ("Green Thumb"), a national cannabis consumer packaged goods company and retailer, promotes well-being through the power of cannabis while giving back to the communities in which it serves. Green Thumb manufactures and distributes a portfolio of branded cannabis products including Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles and RYTHM. The company also owns and operates rapidly growing national retail cannabis stores called RISE. Headquartered in Chicago, Illinois, Green Thumb has 17 manufacturing facilities, 77 open retail locations and operations across 15 U.S. markets. Established in 2014, Green Thumb employs approximately 4,000 people and serves millions of patients and customers each year. The company was named to Crain's Chicago Business, Fast 50 list in 2021 and 2022 and a Best Workplace by MG Retailer magazine in 2018, 2019 and 2021. More information is available at www.GTIgrows.com .
News Provided by GlobeNewswire via QuoteMedia
New dispensary expands patient access to medical cannabis; grand opening specials available
Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the United States today announced the grand opening of a new medical dispensary in Morgantown - Granville, WV . Located at 525 Granville Square, the doors open at 10 a.m. on Friday, July 1, 2022 .
The 5,100 square-foot dispensary is situated in a highly trafficked area of Morgantown , adjacent to University Town Center and within the Granville Square Shops outlet mall. The Company's fifth retail location in West Virginia will be open seven days a week from 10am – 6pm and features enhanced visual elements and robust product offerings.
Grand opening festivities will be held on Saturday, July 9 throughout the day to include partner giveaways, deals and specials, and all registered patients will receive a 25% discount. On-site medical care specialists will be available to assist with medical card registration and certification for West Virginia patients.
"In the past year, West Virginia's medical cannabis program has added nearly 10,000 patients, and we are thrilled to serve this flourishing community through our newest location," said Chief Executive Officer Kim Rivers , "Trulieve's growing retail footprint demonstrates our ongoing commitment to provide the best quality services and products for the state's registered medical cannabis patients. We look forward to supporting our patients throughout their cannabis journey and strengthening community connections in this developing market."
Trulieve patients across West Virginia can choose from a large selection of THC and CBD products available in a variety of consumption methods, including flower, concentrates, tinctures, topicals, ingestibles, and more. Designed to meet every patient's needs, our portfolio of in-house brands includes Cultivar Collection, Momenta, Muse, TruFlower and more.
Last November , Trulieve opened West Virginia's first dispensary and has since expanded its store hours to welcome patients seven days a week. This will be Trulieve's second location in Morgantown . The Company has already opened three new dispensaries in the state this year, with plans to open four additional dispensary locations by the end of the year in Milton , Hurricane , Huntington and Belle .
For more information on store locations, please visit https://www.trulieve.com/dispensaries/west-virginia .
About Trulieve Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S. operating in 11 states, with leading market positions in Arizona , Florida , and Pennsylvania . Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit Trulieve.com .
Facebook: @Trulieve Instagram: @Trulieve_ Twitter: @Trulieve
Investor Contact Christine Hersey , Executive Director of Investor Relations +1 (424) 202-0210 Christine.Hersey@Trulieve.com
Media Contact Rob Kremer , Executive Director of Corporate Communications +1 (404) 218-3077 Robert.Kremer@Trulieve.com
MATTIO Communications Trulieve@Mattio.com
View original content to download multimedia: https://www.prnewswire.com/news-releases/trulieve-opening-morgantown-wv-medical-dispensary-301579321.html
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/July2022/01/c3969.html
News Provided by Canada Newswire via QuoteMedia
New dispensary expands patient access to medical cannabis; grand opening specials available
Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the United States today announced the opening of a new medical dispensary in Coral Springs, Florida . Located at 10400 W. Atlantic Blvd., the doors will open at 9am on Friday, July 1, 2022 . The dispensary will be open seven days a week, hours are Monday through Saturday from 9am 9pm and on Sunday from 10am 8pm .
Grand opening festivities throughout the day at the new dispensary will include numerous partner giveaways, music, food trucks, deals and specials, and all registered patients will receive a 25% discount. Trulieve also offers statewide home delivery, convenient online ordering and in-store pickup. As always, all first-time guests are eligible for a 50% new customer discount at any Florida -based location.
"Trulieve is proud to continue being at the forefront of expanding access to medical marijuana for Florida's patient population," said Trulieve's Chief Executive Officer Kim Rivers , "Trulieve is committed to investing in the Coral Springs community, as well as offering patients access to high quality products and providing exceptional customer experiences."
As the state's leading medical cannabis provider, Trulieve's retail employees are trained to provide personalized patient care and support individuals at every stage of their cannabis journeys. Trulieve dispensaries throughout Florida offer on-site consultations to help patients obtain appropriate medical products and dosages that ensure optimal cannabis experiences.
Trulieve patients across Florida can choose from the largest selection of THC and CBD products available in a variety of consumption methods, including smokable flower, concentrates, edibles, capsules, syringes, tinctures, topical creams, vaporizers, and more.
Designed to meet every patient's needs, our portfolio of in-house brands includes Alchemy, Co2lors, Cultivar Collection, Modern Flower, Momenta, Muse, Roll One and Sweet Talk. Patients also have access to beloved brands such as Bellamy Brothers , Bhang, Binske, Blue River , Black Tuna, DeLisioso, Love's Oven, Miami Mango, O.pen and Sunshine Cannabis, all available exclusively at Trulieve in Florida .
For more information, or to learn how to become a registered patient, please visit Trulieve.com .
About Trulieve Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S. operating in 11 states, with leading market positions in Arizona , Florida , and Pennsylvania . Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit Trulieve.com .
Facebook: @Trulieve Instagram: @Trulieve_ Twitter: @Trulieve
Investor Contact Christine Hersey , Executive Director of Investor Relations +1 (424) 202-0210 Christine.Hersey@Trulieve.com
Media Contact Rob Kremer , Executive Director of Corporate Communications +1 (404) 218-3077 Robert.Kremer@Trulieve.com
View original content to download multimedia: https://www.prnewswire.com/news-releases/trulieve-opening-coral-springs-fl-medical-dispensary-301579230.html
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/July2022/01/c4857.html
News Provided by Canada Newswire via QuoteMedia
Canopy Growth Corporation (" Canopy Growth " or the " Company ") (TSX: WEED) (NASDAQ: CGC) announced today that, further to its press release dated June 29, 2022 it has entered into an additional privately negotiated exchange agreement (the " Exchange Agreement ") with a holder (the " Noteholder ") of the Company's outstanding 4.25% unsecured senior notes due 2023 (the " Notes "), to acquire approximately C$7.25 million (approximately USD$5.6 million ) aggregate principal amount of the Notes from the Noteholders in exchange for common shares of the Company (the " Canopy Shares ") and approximately C$140,000 (approximately USD$110,000 ) in cash for accrued and unpaid interest (the " Cash Payment ").
In accordance with the terms of the Exchange Agreement, Canopy Growth has agreed to acquire the Notes from the Noteholder for an aggregate purchase price (excluding accrued and unpaid interest which will be paid in cash as part of the Cash Payment) of C$7.17 million (approximately USD$5.5 million ) (the " Purchase Price "), which will be payable in such number of Canopy Shares (the " Share Consideration ") as is equal to the Purchase Price divided by the volume-weighted average trading price (the " VWAP ") of the Canopy Shares on the Nasdaq Global Select Market (the " Nasdaq ") for the 10 consecutive trading days beginning on, and including, June 30, 2022 (the " Averaging Price " and such period of time being the " Averaging Period "), subject to a floor price of US$2.50 (the "Floor Price") and a maximum price equal to US$3.50 , which is the closing price of the Canopy Shares on the Nasdaq on June 29, 2022 (the " Market Price ").
The Share Consideration will be satisfied by the issuance of Canopy Shares in up to two tranches as follows: (a) on the initial closing, 1,589,260 Canopy Shares (the " Initial Closing Shares ") will be issued to the Noteholder; and (b) in the event that the Averaging Price calculated over the Averaging Period is less than the Market Price, on or about July 18, 2022 (the " Final Closing "), up to such number of Canopy Shares as is equal to the excess of the Purchase Price divided by the Averaging Price over the Initial Closing Shares.
In the event that the daily VWAP of the Canopy Shares on the Nasdaq during the Averaging Period (a) exceeds the Market Price, then the daily VWAP for such trading day will instead be deemed to be the Market Price; or (b) is less than the Floor Price, then the daily VWAP for such trading day will instead be deemed to be the Floor Price, such that in no circumstances will more than 2,224,965 Canopy Shares be issuable pursuant to the Noteholder.
Together with the exchange agreements (the " Other Exchange Agreements ") entered into prior to the announcement on June 29, 2022 (collectively, the " Transaction "), a minimum of 35,662,420 Canopy Shares have been or will be issued. Pursuant to the terms of the Exchange Agreement and the Other Exchange Agreements, in no circumstances will more than 80,629,270 Canopy Shares be issuable pursuant to the Transaction.
The Transactions are being conducted as private placements, and any Canopy Shares to be issued in the Transaction will be issued pursuant to the exemption from the registration requirements of the Securities Act of 1933, as amended (the " Securities Act "), afforded by Section 4(a)(2) of the Securities Act in transactions not involving any public offering. This press release is neither an offer to sell nor a solicitation of an offer to buy any securities described above, nor will there be any offer, solicitation or sale of any securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.
Canopy Growth (TSX:WEED, NASDAQ:CGC) is a world-leading diversified cannabis and cannabinoid-based consumer product company, driven by a passion to improve lives, end prohibition, and strengthen communities by unleashing the full potential of cannabis. Leveraging consumer insights and innovation, Canopy Growth offers product varieties in high-quality dried flower, oil, softgel capsule, infused beverage, edible, and topical formats, as well as vaporizer devices by Canopy Growth and industry-leader Storz & Bickel. Canopy Growth's global medical brand, Spectrum Therapeutics, sells a range of full-spectrum products using its colour-coded classification system and is a market leader in both Canada and Germany . Through Canopy Growth's award-winning Tweed and Tokyo Smoke banners, Canopy Growth reaches its adult-use consumers and has built a loyal following by focusing on top quality products and meaningful customer relationships. Canopy Growth has entered into the health and wellness consumer space in key markets including Canada , the United States , and Europe through BioSteel sports nutrition, and This Works skin and sleep solutions; and has introduced additional hemp derived CBD products to the United States through its First & Free and Martha Stewart CBD brands. Canopy Growth has an established partnership with Fortune 500 alcohol leader Constellation Brands.
This news release contains "forward-looking statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995 and "forward-looking information" within the meaning of applicable Canadian securities legislation. Often, but not always, forward-looking statements and information can be identified by the use of words such as "plans", "expects" or "does not expect", "is expected", "estimates", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward-looking statements or information involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company or its subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements or information contained in this news release. Examples of such statements and uncertainties include statements with respect to the benefits of the debt repurchase, the anticipated date of issuance of the Initial Closing Shares, the anticipated date of the issuance of any additional Canopy Shares following the Averaging Period and expectations for other economic, business, and/or competitive factors .
Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, including inherent uncertainty associated with projections; the diversion of management time on Transaction-related issues; expectations regarding future investment, growth and expansion of operations; regulatory and licensing risks; changes in general economic, business and political conditions, including changes in the financial and stock markets and the impacts of increased rates of inflation; legal and regulatory risks inherent in the cannabis industry, including the global regulatory landscape and enforcement related to cannabis, political risks and risks relating to regulatory change; risks relating to anti-money laundering laws; compliance with extensive government regulation and the interpretation of various laws regulations and policies; public opinion and perception of the cannabis industry; and such other risks contained in the public filings of the Company filed with Canadian securities regulators and available under the Company's profile on SEDAR at www.sedar.com and with the United States Securities and Exchange Commission through EDGAR at www.sec.gov/edgar , including the Company's annual report on Form 10-K for the year ended March 31, 2022 .
In respect of the forward-looking statements and information, the Company has provided such statements and information in reliance on certain assumptions that they believe are reasonable at this time. Although the Company believes that the assumptions and factors used in preparing the forward-looking information or forward-looking statements in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. Should one or more of the foregoing risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. The forward-looking information and forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake any obligation to publicly update such forward-looking information or forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities laws.
View original content to download multimedia: https://www.prnewswire.com/news-releases/canopy-growth-announces-additional-exchanges-with-holders-of-notes-301579205.html
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/June2022/30/c3730.html
News Provided by Canada Newswire via QuoteMedia
Centurion Minerals Ltd. (TSXV: CTN) (the "Company") announces that the consolidation of its common shares will become effective July 6, 2022, and all common shares will be consolidated on a 2:1 basis, such that for every 2 common shares presently held, shareholders will receive 1 post-consolidated common share.
Centurion currently has 33,639,473 common shares outstanding which will, on a post-consolidation basis, result in approximately 16,819,736 common shares outstanding. There are no stock options or warrants outstanding and the Company's name and trading symbol will remain the same.
The Company's new CUSIP # is: 15643T404 and the ISIN # is: CA 15643T4046.
A Letter of Transmittal will be mailed to registered shareholders holding physical certificates by the Company's transfer agent, Endeavor Trust Company, advising that the consolidation has taken effect and those shareholders should surrender their existing common share certificates, for new (post-consolidation) common share certificates. No fractional common shares of the Company shall be issued in connection with the consolidation and the number of common shares to be received by a shareholder shall be rounded down to the nearest whole number of common shares.
Centurion will apply to the TSXV Exchange for a resumption of trading as a mineral exploration issuer following its Annual General and Special meeting to be held on August 12, 2022.
Centurion Minerals Ltd. is a Canadian-based company with a focus on mineral asset development in the Americas. The Company's lead investment is its interest in the Ana Sofia Agri-Gypsum Fertilizer Project, and it is also reviewing additional prospective, precious mineral exploration projects.
"David G. Tafel" President and CEO
For Further Information Contact: David Tafel 604-484-2161
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cautionary Statement Regarding Forward-Looking Information
All statements, trend analysis and other information contained in this press release about anticipated future events or results constitute forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as "seek", "anticipate", "believe", "plan", "estimate", "expect" and "intend" and statements that an event or result "may", "will", "should", "could" or "might" occur or be achieved and other similar expressions. All statements, other than statements of historical fact, included herein, including, without limitation, statements regarding, the completion of the Arrangement, the Meeting, the Final Order hearing of the Court, the anticipated benefits of the Arrangement, the Company's plan to develop its business and provide Shareholders with additional investment choices and enhanced value, the Company's plans to complete the Consolidation and the Company's plans to apply to the TSX-V for a resumption of trading as a mineral exploration issuer following the Meeting are forward-looking statements. Although the Company believes that the expectations reflected in such forward-looking statements and/or information are reasonable, undue reliance should not be placed on forward-looking statements since the Company can give no assurance that such expectations will prove to be correct. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements, including the risks, uncertainties and other factors identified in the Company's periodic filings with Canadian securities regulators, and assumptions made with regard to: the Company's ability to complete the proposed Arrangement on the terms and conditions contemplated, or at all; the Companies' ability to secure the necessary shareholder, Court and regulatory approvals required to complete the Arrangement; the estimated costs associated with the Arrangement; the timing of the Meeting, the Final Order hearing and the Arrangement, and the general stability of the economy and the industry in which the Company operates . Forward-looking statements are subject to business and economic risks and uncertainties and other factors that could cause actual results of operations to differ materially from those contained in the forward-looking statements. Important factors that could cause actual results to differ materially from the Company expectations include risks associated with the business of the Company; risks related to the satisfaction or waiver of certain conditions to the closing of the Arrangement; non-completion of the Arrangement; risks related to the Company failing to obtain the requisite shareholder approval required for the Arrangement; risks relating the number of dissenting shareholders requiring fair value for their securities in connection with the Arrangement; risks related to exploration and potential development of the Company projects; business and economic conditions in the mining and cannabis industries generally; fluctuations in commodity prices and currency exchange rates; the need for cooperation of government agencies and native groups in the issuance of required permits; the need to obtain additional financing to develop properties, or cannabis-related assets, and uncertainty as to the availability and terms of future financing; and other risk factors as detailed from time to time and additional risks identified in the Company filings with Canadian securities regulators on SEDAR in Canada (available at www.sedar.com). Forward-looking statements are based on estimates and opinions of management at the date the statements are made. The Company does not undertake any obligation to update forward-looking statements except as required by applicable securities laws. Investors should not place undue reliance on forward-looking statements.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/129673
News Provided by Newsfile via QuoteMedia
Round Led by JW Asset Management to Advance House of Brands Strategy
Tyson 2.0 is Licensed in over 20 States and has Sold Over 4,000 lbs of Cannabis Flower
Tyson 2.0 ("The Company"), iconic boxer, entrepreneur and cannabis advocate Mike Tyson's cannabis brand, has taken the nation by storm by becoming a consumer favorite in over 20 US states and Canada since its launch late last year. In that time, Tyson 2.0 has sold over 4,000 pounds of cannabis flower across North America . Today, the Company announced the close of its oversubscribed $9 Million Series A round led by JW Asset Management. Additional investors in the round include K2, Ambria Capital, Tress Capital, and Patrick Carroll .
Tyson 2.0 Co-founder, President and Chairman, Chad Bronstein said, " Mike Tyson and our team believed early on that building high-quality cannabis brands and products backed by A-list celebrities would be a winning combination. Our model has shown early validation with robust sales and expansion of the brand to more than 20 states including several of the world's leading operators. The next step in our journey will require us to put more capital to work, and I couldn't think of a better set of partners than the group of investors we have assembled, highlighted by Jason Wild and the team at JW Asset Management."
The raised funds will be used to acquire more celebrity intellectual property, scale marketing efforts, accelerate distribution, and further invest in the development of Tyson 2.0's house of brands strategy.
"I've had the pleasure of working with and knowing Chad and Adam for many years. I am impressed with how quickly they have scaled the business becoming one of the leading national cannabis brands on the market today. With the ability to develop additional products from celebrities like Mike Tyson , Ric Flair , and more to come, I am confident the strong momentum can continue," said Jason Wild , President and Chief Investment Officer, JW Asset Management.
Tyson 2.0 is also pleased to announce the appointment of Nicole Cosby as its Chief Legal and Licensing Officer. Cosby also served as Chief Data and Compliance Officer of Fyllo Group and prior to this, held the position of Senior Vice President of Standards at Publicis Group. Cosby is an attorney by trade and has a background in digital advertising/data policy and brand strategy/licensing.
Bronstein concluded, "This is just the beginning, Tyson 2.0 is being sought out by some of the hottest pop culture icons who are cannabis advocates and users, and want the opportunity to share their love of the plant with their fans."
For more information on Tyson 2.0, visit Tyson20.com . Tyson 2.0-branded merchandise is available for purchase at shoptyson20.com .
About JW Asset Management JW Asset Management is a New York based fund manager with combined assets under management of approximately $1 billion . Jason Wild , the firm's founder and Chief Investment Officer, is a registered pharmacist and Executive Chairman of TerrAscend Corp (CSE:TER,OTCQX:TRSSF). JW Asset Management has a history of finding attractive investment opportunities across the healthcare and cannabis industries and actively invests in both public and private markets.
About Tyson 2.0 Tyson 2.0 is a premier cannabis company formed with legendary boxer, entrepreneur and icon Mike Tyson . The company's mission is to produce innovative, high-quality cannabis products known for purity, precision, and wide accessibility. Providing consumers an outstanding selection of products, Tyson 2.0 is an extraordinary balance of premium and affordable, full-spectrum cannabis flower, concentrates and consumables available at retailers nationwide. Learn more at Tyson20.com .
View original content to download multimedia: https://www.prnewswire.com/news-releases/tyson-2-0-completes-9-million-series-a-to-expand-celebrity-brand-portfolio-301578802.html
News Provided by PR Newswire via QuoteMedia
Leading global cannabis company continues to expand beverage portfolio with exciting new products
Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC), a world-leading diversified cannabis, hemp, and cannabis device company, today announced the continued expansion of its cannabis beverage portfolio and a brand campaign that drives awareness of its wide range of cannabis beverages just in time for the summer season. Boasting the category's fastest growing brands, 1 Canopy Growth continues to show its leadership in beverages and ongoing commitment to meeting customer demand.
The Company showcases its diverse portfolio of cannabis beverages in its new Just Hits Different brand campaign which offers adult consumers a new way to enjoy familiar experiences, and a different type of drink to consume during special summer occasions like long weekends. The campaign comes to life across digital and social channels and aims to drive traffic, create awareness, and convert sales in store.
The campaign also features an interactive and educational flavour sampling program, the biggest the category has ever seen. Consumers can visit one of more than 1,400 Canadian cannabis retail locations to try a non-active flavour sample of products like Tweed Fizz Mango, Tweed Iced Tea Lemon, Deep Space Limon Splashdown, and Quatreau Passionfruit & Guava. The pop-up sampling events give consumers an opportunity to learn about the products, engage with brand ambassadors, and experience the flavours before adding them to their shopping cart.
When consumers arrive in store, they will see a bigger-than-ever range of flavour-forward cannabis beverages from brands like Tweed, a 5 mg THC segment leader, and Deep Space, a high potency 10mg THC brand known for its bold, nostalgic flavours with a unique twist. Familiar favourites from Quatreau and Ace Valley , plus new offerings from Vert, round out the summer line-up, giving consumers a wide variety of options.
To make room for its new offerings and increased distribution, 785 fridges have been added in retail locations across the country, quadrupling their fridge footprint and further emphasizing the breadth and depth of their beverage portfolio.
"Our insights tell us that taste and seasonality play a key role in consumer choice, which is why we're excited to offer a range of new and familiar flavours for the summer," said Tara Rozalowsky , Vice President, Brand Marketing at Canopy Growth. "Our sampling events give consumers a chance to try our great-tasting beverage flavours, so when they're ready to add a beverage to their basket and experience cannabis in a whole new way, they know what our brands have to offer."
In addition to the recently announced Deep Space Orange Orbit and The Grape Unknown and range of Tweed Fizz and cannabis iced tea beverages, consumers will be able to enjoy three new beverage offerings debuting this summer:
Canopy Growth's beverage offerings are available for purchase via legal recreational cannabis retail locations and e-commerce channels, with select products available in certain regions and for a limited time only.
Canopy Growth (TSX: WEED, NASDAQ: CGC) is a world-leading diversified cannabis and cannabinoid-based consumer product company, driven by a passion to improve lives, end prohibition, and strengthen communities by unleashing the full potential of cannabis. Leveraging consumer insights and innovation, we offer product varieties in high-quality dried flower, oil, softgel capsule, infused beverage, edible, and topical formats, as well as vaporizer devices by Canopy Growth and industry-leader Storz & Bickel. Our global medical brand, Spectrum Therapeutics, sells a range of full-spectrum products using its colour-coded classification system and is a market leader in both Canada and Germany . Through our award-winning Tweed and Tokyo Smoke banners, we reach our adult-use consumers and have built a loyal following by focusing on top quality products and meaningful customer relationships. Canopy Growth has entered into the health and wellness consumer space in key markets including Canada , the United States , and Europe through BioSteel sports nutrition, and This Works skin and sleep solutions; and has introduced additional federally-permissible CBD products to the United States through our First & Free and Martha Stewart CBD brands. Canopy Growth has an established partnership with Fortune 500 alcohol leader Constellation Brands. For more information visit www.canopygrowth.com.
This press release contains "forward-looking statements" and "forward-looking information" within the meaning of applicable U.S. and Canadian securities laws (collectively, "forward-looking statements"), which involve certain known and unknown risks and uncertainties. Forward-looking statements predict or describe our future operations, business plans, business and investment strategies and the performance of our investments. These forward-looking statements are generally identified by their use of such terms and phrases as "intend," "goal," "strategy," "estimate," "expect," "project," "projections," "forecasts," "plans," "seeks," "anticipates," "potential," "proposed," "will," "should," "could," "would," "may," "likely," "designed to," "foreseeable future," "believe," "scheduled" and other similar expressions. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date the statement was made. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive risks, financial results, results, performance or achievements expressed or implied by those forward-looking statements and the forward-looking statements are not guarantees of future performance. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. A discussion of some of the material factors applicable to Canopy Growth Corporation ("Canopy") can be found under the section entitled "Risk Factors" in Canopy's Annual Report on Form 10-K for the year ended March 31, 2022 , filed with the Securities and Exchange Commission and with applicable Canadian securities regulators, as such factors may be further updated from time to time in its periodic filings with the Securities and Exchange Commission and with applicable Canadian securities regulators, which can be accessed at www.sec.gov/edgar and www.sedar.com, respectively. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this press release and in the filings. Any forward-looking statement included in this press release is made as of the date of this press release and, except as required by law, Canopy disclaims any obligation to update or revise any forward- looking statement. Readers are cautioned not to put undue reliance on any forward-looking statement. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.
1 CGC Internal Data, May 2022, calculated using internal proprietary market share tool that utilizes point of sales data supplied by a third-party data provider, government agencies and our own retail store operations across the country.
2 Datassential, US Chains & Independents 2021, CSD Flavours, Menu Penetration by Segment
View original content to download multimedia: https://www.prnewswire.com/news-releases/canopy-growth-celebrates-summer-with-new-just-hits-different-beverage-campaign-301578752.html
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/June2022/30/c9702.html
News Provided by Canada Newswire via QuoteMedia
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.